{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00219323",
      "orgStudyIdInfo": {
        "id": "CIGE025A1307"
      },
      "organization": {
        "fullName": "Novartis",
        "class": "INDUSTRY"
      },
      "briefTitle": "Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.",
      "officialTitle": "Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma"
    },
    "statusModule": {
      "statusVerifiedDate": "2011-10",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2003-11"
      },
      "primaryCompletionDateStruct": {
        "date": "2006-03",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2006-03",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2005-09-21",
      "studyFirstSubmitQcDate": "2005-09-21",
      "studyFirstPostDateStruct": {
        "date": "2005-09-22",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2011-10-24",
      "lastUpdatePostDateStruct": {
        "date": "2011-10-25",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "leadSponsor": {
        "name": "Novartis",
        "class": "INDUSTRY"
      },
      "collaborators": [
        {
          "name": "Daiichi Sankyo Co., Ltd.",
          "class": "INDUSTRY"
        }
      ]
    },
    "descriptionModule": {
      "briefSummary": "This study will evaluate the safety and efficacy of omalizumab up to 48 weeks in adult patients with moderate to severe bronchial asthma.\n\nTHIS STUDY IS NOT ENROLLING PATIENTS IN THE UNITED STATES"
    },
    "conditionsModule": {
      "conditions": [
        "Asthma"
      ],
      "keywords": [
        "Asthma, IgE, Omalizumab"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "NON_RANDOMIZED",
        "interventionModel": "SINGLE_GROUP",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 133,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "interventions": [
        {
          "type": "DRUG",
          "name": "Omalizumab"
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Safety of omalizumab"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Pulmonary function parameters measured by spirometer"
        },
        {
          "measure": "Morning and evening peak expiratory flow (PEF)"
        },
        {
          "measure": "Symptoms score, treatment score, activities of daily living score, nighttime sleep score, and asthma score"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Allergic asthma patients\n* Inadequately controlled patients\n\nExclusion Criteria:\n\n* \\- History of severe anaphylactoid or anaphylactic reactions\n* Previous treatment with omalizumab\n* History of cancer or cancer\n\nOther protocol-defined exclusion criteria may apply.",
      "sex": "ALL",
      "minimumAge": "20 Years",
      "maximumAge": "75 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Novartis Pharmaceuticals Japan",
          "affiliation": "Novartis Pharmaceuticals Japan",
          "role": "STUDY_CHAIR"
        }
      ],
      "locations": [
        {
          "facility": "This study is not being conducted in the United States",
          "city": "Tokyo",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.6895,
            "lon": 139.69171
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D001249",
          "term": "Asthma"
        },
        {
          "id": "C562694",
          "term": "Epilepsy, Idiopathic Generalized"
        }
      ],
      "ancestors": [
        {
          "id": "D001982",
          "term": "Bronchial Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D008173",
          "term": "Lung Diseases, Obstructive"
        },
        {
          "id": "D008171",
          "term": "Lung Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D000069444",
          "term": "Omalizumab"
        }
      ],
      "ancestors": [
        {
          "id": "D000888",
          "term": "Antibodies, Anti-Idiotypic"
        },
        {
          "id": "D000906",
          "term": "Antibodies"
        },
        {
          "id": "D007136",
          "term": "Immunoglobulins"
        },
        {
          "id": "D007162",
          "term": "Immunoproteins"
        },
        {
          "id": "D001798",
          "term": "Blood Proteins"
        },
        {
          "id": "D011506",
          "term": "Proteins"
        },
        {
          "id": "D000602",
          "term": "Amino Acids, Peptides, and Proteins"
        },
        {
          "id": "D061067",
          "term": "Antibodies, Monoclonal, Humanized"
        },
        {
          "id": "D000911",
          "term": "Antibodies, Monoclonal"
        },
        {
          "id": "D012712",
          "term": "Serum Globulins"
        },
        {
          "id": "D005916",
          "term": "Globulins"
        }
      ]
    }
  },
  "hasResults": false
}